COVID-19 Resources

Every nurse can play an important role in educating our families, friends, neighbors and community programs. Stay informed! Here are a couple of ways you can get involved or stay up-to-date.

COVID-19 Video Education Options – Watch Full Webinars or Quick Videos

In addition to 8 COVID-19 topics covered in free 60-minute webinars, ANA also offers the option of watching quick videos (5-15 minutes each) for those who prefer their education in quick bites.  We have reached almost 600,000 registrations on our webinars and 160,000 views of the Quick Videos already.

Registration is necessary to view the full webinars and can be done here. The Quick Videos are available for viewing immediately on the webpages.

To access the newest COVID quick videos, click on the links below to visit our webpage on that topic.

• Boosting Vaccine Confidence in Minority Populations 
• COVID-19 Vaccines
• COVID-19 and Your Mental Health
• Ambulatory APRNs on the Frontlines quick Videos
• PPE quick videos
• Ethics quick videos

See our redesigned main page for all the ANA COVID-19 Video Education topics here. The education videos are available to ALL nurses.

ANA’s COVID-19 Resource Center

The expanded COVID-19 Resource Center highlights clinical information, ethical considerations, ANA’s legislative and regulatory activities, and frequently asked questions, and features the COVID-19 work that ANA is doing.

We encourage you to visit the Resource Center frequently to stay updated.

COVID-19 Booster Dose Messaging and Outreach Tools

Millions of Americans are now eligible to get a COVID-19 booster dose. The following communications resources — including topline talking points, answers to tough questions, sample social media posts and graphics — can help you answer questions about COVID-19 vaccine booster doses and support your local vaccination outreach.

• Topline Messages
• Answers to Tough Questions
• Social Media Sample Posts and Shareable Graphics

Monkeypox Resources

MDHHS updated vaccine recommendations for monkeypox virus (MPV) based on a recent announcement from the U.S. Food and Drug Administration (FDA).

FDA’s Emergency Use Authorization (EUA) now allows providers to offer the vaccine as an injection between layers of the skin, or intradermally, which increases the number of doses up to five-fold and has the same immune response.

• The vaccine, JYNNEOS, is administered as two doses 28 days apart. People who received a first dose should contact their local health department or provider to receive a second dose 28 days after the first.
• People are considered fully vaccinated approximately two weeks after their second dose.
• If more than 28 days have passed since receiving the first dose, individuals should receive their second dose as soon as possible and do not have to restart the series.

Who should get the monkeypox vaccine?

• MDHHS is urging anyone who is at risk, who has been exposed or suspects they have been exposed to the virus to contact their local health department about vaccination.
• MPV can spread to anyone through close, personal often skin-to-skin contact.

What is monkeypox and how does it spread?

• MPV is a disease caused by infection with the monkeypox virus.
• While both diseases may seem similar, MPV is not related to chickenpox.
• MPV can spread to anyone through close, personal often skin-to-skin contact including:
• Direct contact with MPV rash, scabs or body fluids from a person with MPV. It is believed this is currently the most common way that MPV is spreading in the U.S.
• Through contact with someone with MPV during common activities such as sex, hugging, massaging, kissing and prolonged face-to-face contact.
• Touching objects, fabrics (clothing, bedding or towels) and surfaces that have been used by someone with MPV.
• Contact with respiratory secretions.

When interacting with other people including groups at large events consider how much close, personal, skin-to-skin contact is likely to occur at the event you plan to attend.

Where can I find more information?

To help keep Michiganders up to date on monkeypox (MPV) and the state’s response to the virus, MDHHS launched a new website.

Michigan.gov/mpv provides information about:

• Signs and symptoms of MPV
• Number of cases in the state by county
• Information for health care providers about testing and coordinating with local health departments
• Treatment and other resources for the public and providers.

Additional resources to share:

• MDHHS MPV information, plus resources for local health departments, providers and the public in Michigan: Michigan.gov/MPV
• CDC MPV information: CDC.gov/monkeypox
• Additional fact sheets, graphics, and other materials to share with the public: CDC.gov/poxvirus/monkeypox/resources

ANA has kicked off a multi-phase effort of accountability, healing, and reconciliation with the public release of its official racial reckoning statement, which the voting representatives of ANA’s Membership Assembly unanimously voted “yes” on last month. With this public release, ANA acknowledges its own past actions that have caused irreparable harm to nurses of color and that have perpetuated systemic racism. It is their hope that this work will begin to strengthen who they are as a professional association and the broader nursing profession through inclusion, diversity, and equity as we all strive for antiracist nursing practices and environments.

Racism in Nursing

Racial Reckoning Statement

FAQs

President Grant’s Column in the American Nurse Journal

Stay informed on our racial reconciliation work here

Media Statement

ANA Enterprise CEO Loressa Cole Delivers Formal Apology (VIDEO)